Latanoprost-Timolol Ab

Timolol maleate and latanoprost, the active ingredients in Latanoprost‑Timolol Ab, are a beta‑blocker and a prostaglandin analog presented as eye drops for ocular use. They lower intra‑ocular pressure in adults with open‑angle glaucoma or ocular hypertension. The combination is indicated for chronic management of elevated intra‑ocular pressure and is formulated for convenient once‑daily dosing.

GNH USA supplies Latanoprost‑Timolol Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics for ocular products.

Latanoprost‑Timolol Ab is used in the management of ocular conditions characterized by elevated intra‑ocular pressure.

Open-angle glaucoma: reduces intra‑ocular pressure to prevent progressive optic nerve damage. Ocular hypertension: lowers elevated eye pressure to reduce the risk of developing glaucoma. Steroid‑induced secondary glaucoma: helps control pressure when corticosteroid therapy elevates intra‑ocular pressure.

The most frequently reported ocular and systemic reactions to Latanoprost‑Timolol Ab are listed below.

Common Side Effects: - Eye irritation or burning sensation: mild discomfort after instillation. - Blurred vision: transient visual disturbance. - Conjunctival hyperemia: redness of the eye. - Dry eye: reduced tear production.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or anaphylaxis requiring immediate medical attention. - Significant decrease in heart rate or bronchospasm: especially in patients with asthma or cardiac disease. - Changes in iris pigmentation: permanent darkening of the iris.

Before prescribing Latanoprost‑Timolol Ab, clinicians should consider the following precautions.

Assess cardiovascular status: avoid in patients with uncontrolled bradycardia or heart block. Screen for respiratory disease: use with caution in asthma or chronic obstructive pulmonary disease. Monitor intra‑ocular pressure: regular measurements are required to evaluate efficacy. Avoid concurrent use with other beta‑blocker eye drops: may increase systemic absorption. Store below 25°C: keep in the original container, protect from light and moisture.

Latanoprost‑Timolol Ab may interact with other medicines; notable interactions are categorized below.

Major Interactions (Avoid): - Non‑selective beta‑blockers (oral or topical): additive bradycardia or hypotension. - Calcium channel blockers: increased risk of heart block when combined with timolol. - Prostaglandin analogs (other eye drops): may enhance ocular side effects such as hyperemia.

Moderate Interactions (Monitor Closely): - Systemic antihypertensives: monitor blood pressure for additive lowering effect. - Respiratory bronchodilators (e.g., albuterol): timolol may reduce bronchodilator efficacy. - MAO inhibitors: potential for increased systemic beta‑blocker effects.